0001203311-16-000080.txt : 20160407
0001203311-16-000080.hdr.sgml : 20160407
20160407164931
ACCESSION NUMBER: 0001203311-16-000080
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160405
FILED AS OF DATE: 20160407
DATE AS OF CHANGE: 20160407
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SIEGALL CLAY B
CENTRAL INDEX KEY: 0001167496
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 161560571
MAIL ADDRESS:
STREET 1: 21823 30TH DR SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2016-04-05
0
0001060736
SEATTLE GENETICS INC /WA
SGEN
0001167496
SIEGALL CLAY B
21823 30TH DRIVE SE
BOTHELL
WA
98021
1
1
0
0
President and CEO
Common Stock
2016-04-05
4
M
0
7618.0
4.45
A
563733
D
Common Stock
2016-04-05
4
S
0
7618.0
36.12
D
556115
D
Common Stock
27945
I
by Trust
Non-Qualified Stock Option (right to buy)
4.45
2016-04-05
4
M
0
7618.0
0.0
D
2016-09-05
Common Stock
7618
38083
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Sale price represents a weighted average price for all shares sold on this day, which are within a $1.00 range.
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
Shares vested at a rate of 25% on 9/06/07 and monthly thereafter until all the shares were fully vested on 9/06/10.
/s/ Clay B. Siegall
2016-04-06